Uttarakhand Intensifies Clampdown on Banned Cough Syrups
Uttarakhand has launched a comprehensive, statewide crackdown on banned cough syrups following directives from Chief Minister Pushkar Singh Dhami. Subsequently, the Food and Drug Administration (FDA) is conducting extensive raids on medical stores, wholesalers, and hospital pharmacies across all districts. This initiative prioritizes child safety and public health throughout the state.
Central Advisory and Public Health Concerns
The state’s stringent actions align with a crucial advisory from the Central Government concerning the rational use of cough syrups for children. The Union Health Ministry advises against prescribing or dispensing cough and cold medications to children below two years, further recommending against their general use for children under five years. Additionally, careful clinical evaluation, close supervision, and strict adherence to appropriate dosing are vital for any use in children above five.
This campaign originated in response to recent tragic incidents in Rajasthan and Madhya Pradesh, where the consumption of certain cough syrups unfortunately led to child fatalities. Health Secretary and Commissioner, Food Safety and Drug Administration (FDA), Dr. R. Rajesh Kumar, stressed the paramount importance of child safety and public health, ordering all Chief Medical Officers to enforce the Central Government’s advisory immediately.
Specific Banned Cough Syrups and Enforcement
The Uttarakhand government has specifically banned syrups containing Dextromethorphan and combinations of chlorpheniramine maleate and phenylephrine hydrochloride for children under four years of age. These fixed-dose combinations have also been restricted by the Central Drugs Standard Control Organisation (CDSCO) due to safety concerns for this age group.
Joint teams from the Health Department and the FDA, acting under instructions from Chief Minister Dhami and Health Minister Dr. Dhan Singh Rawat, are executing intensive raids. Dr. Kumar also directed drug inspectors to systematically collect cough syrup samples for laboratory testing. This ensures that defective or harmful medicines are promptly removed from the market.
Doctor’s Role and Public Awareness
Dr. Kumar further urged all doctors in the state to responsibly follow the Central Government’s advisory. They must refrain from prescribing these restricted banned cough syrups for children, as pharmacies will continue to sell them if doctors prescribe them. Tajbar Singh Jaggi, Additional Commissioner, Food Safety and Drug Administration & Drug Controller, leads the statewide raids. He personally inspected medical stores in areas like Dehradun’s Jogiwala and Mohkampur. Furthermore, drug inspectors across all districts must collect syrup samples from government hospitals, primary health centers, and retail shops within this month for testing.
Chief Minister Pushkar Singh Dhami affirmed that child safety and public health allow no compromise, reiterating the government’s commitment to ensuring safe and quality-standard medicines. Health Minister Dr. Dhan Singh Rawat added that negligence regarding children’s medicines will not be tolerated. Meanwhile, Additional Commissioner Tajbar Singh Jaggi appeals to the public to always consult a doctor before administering any medicine to children. People should immediately contact the nearest health center or hospital if they observe any adverse reaction after medicine consumption.
Frequently Asked Questions
Q1: Why has Uttarakhand launched a crackdown on cough syrups?
The crackdown aims to enhance child safety and public health, following tragic child fatalities in other states linked to certain cough syrups. This action aligns with advisories from the Central Government.
Q2: Which specific cough syrup ingredients are banned for children under four?
The Uttarakhand government has specifically banned syrups containing Dextromethorphan and fixed-dose combinations of chlorpheniramine maleate and phenylephrine hydrochloride for children under four years of age.
Q3: What is the Central Government’s advisory regarding cough syrups for children?
The Central Government advises against prescribing or dispensing cough and cold medications to children below two years, generally recommending against their use for children under five. Any use in older children requires careful clinical evaluation and strict dosing.
References
- Uttarakhand launches statewide crackdown on banned cough syrups following CMDhami’s orders – ETHealthworld
- Centre Issues an Advisory to States on Use of Cough Syrups for Children – Newsonair
- Govt bans select cough syrups for kids below 4 years – The Economic Times
- ‘Cough and cold meds should not be…’: Amid children’s deaths in 2 states, Centre’s advisory – The Indian Express
- CDSCO bans use of Chlorpheniramine Maleate IP 2mg and Phenylephrine HCL IP 5mg drop/ml FDC in kids below 4 years
- Uttarakhand launches statewide crackdown on sale of banned cough syrups | India News
- Rajasthan suspends drug controller, cracks down on key cough syrup supplier – India Today
- DCGI directs popular combination drug for cold and flu to be not used in children under the age of 4 – The Hindu
- Health ministry restricts use of common cold medicine in children below four years – Pharmabiz.com
- Coldrif row: Why are states banning the cough syrup | Explained – Hindustan Times
- Cough syrup deaths: Centre issues advisory for states, UTs; calls for ‘rational use of syrups in paediatric population’ | India News – The Times of India
- Uttarakhand launches raids on medical stores amid child deaths linked to cough syrups
- Anti-cold drug combination banned for kids under 4 years: All you need to know
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.